Afatinib vs Pembrolizumab

## Afatinib vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Afatinib** and **Pembrolizumab**.

## Mechanism of Action

**Afatinib**: Irreversible covalent inhibitor of ErbB family (EGFR/HER1, HER2, HER4) tyrosine kinases.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Afatinib — 37 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Afatinib — C24H25ClFN5O3; Pembrolizumab — N/A.

**Molecular Weight**: Afatinib — 485.9400 g/mol; Pembrolizumab — N/A.

**Type**: Afatinib — Small molecule; Pembrolizumab — Antibody.